MiNK Therapeutics, Inc.
INKT
$11.90
$0.453.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.81M | 9.53M | 13.36M | 14.28M | 1.68M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 277.60K | 264.50K | 276.40K | 253.10K | 274.10K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 212.20K | 232.30K | 211.20K | 0.00 | 55.20K |
| Total Current Assets | 9.30M | 10.02M | 13.85M | 14.53M | 2.01M |
|
|
|||||
| Total Current Assets | 9.30M | 10.02M | 13.85M | 14.53M | 2.01M |
| Net Property, Plant & Equipment | 318.50K | 354.50K | 390.90K | 429.30K | 473.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 9.62M | 10.38M | 14.24M | 14.96M | 2.48M |
|
|
|||||
| Total Accounts Payable | 3.92M | 3.39M | 3.43M | 3.69M | 3.31M |
| Total Accrued Expenses | 1.20M | 1.33M | 1.58M | 1.26M | 1.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 5.18M | 5.73M | 5.51M |
| Total Finance Division Other Current Liabilities | 2.45M | 2.57M | 2.85M | 2.76M | 2.48M |
| Total Other Current Liabilities | 2.45M | 2.57M | 2.85M | 2.76M | 2.48M |
| Total Current Liabilities | 7.57M | 7.29M | 13.03M | 13.43M | 13.16M |
|
|
|||||
| Total Current Liabilities | 7.57M | 7.29M | 13.03M | 13.43M | 13.16M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 16.07M | 15.78M | 15.44M | 15.04M | 14.51M |
| Total Liabilities | 23.64M | 23.06M | 28.47M | 28.48M | 27.67M |
|
|
|||||
| Common Stock & APIC | 149.22M | 147.43M | 143.17M | 141.25M | 126.72M |
| Retained Earnings | -162.55M | -159.42M | -156.68M | -154.07M | -151.19M |
| Treasury Stock & Other | -699.90K | -697.40K | -718.90K | -692.10K | -719.30K |
| Total Common Equity | -14.03M | -12.69M | -14.23M | -13.51M | -25.19M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -14.03M | -12.69M | -14.23M | -13.51M | -25.19M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -14.03M | -12.69M | -14.23M | -13.51M | -25.19M |
|
|
|||||